Researchers sought to better understand the risk for recurrence and precipitants for relapse in anterior uveitis, potentially allowing clinicians to better provide a prognosis and disease course with ...
TEL AVIV, Israel, Oct. 5, 2020 /PRNewswire/ -- Tarsius Pharma, a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat patients with blinding ocular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback